PMC:7696151 / 48268-48495 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"1397","span":{"begin":117,"end":125},"obj":"Species"},{"id":"1398","span":{"begin":148,"end":154},"obj":"Species"},{"id":"1406","span":{"begin":7,"end":10},"obj":"Chemical"},{"id":"1425","span":{"begin":141,"end":146},"obj":"Disease"}],"attributes":[{"id":"A1397","pred":"tao:has_database_id","subj":"1397","obj":"Tax:9606"},{"id":"A1398","pred":"tao:has_database_id","subj":"1398","obj":"Tax:9606"},{"id":"A1406","pred":"tao:has_database_id","subj":"1406","obj":"MESH:D006886"},{"id":"A1425","pred":"tao:has_database_id","subj":"1425","obj":"MESH:D008180"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"ing of HCQ treatment (100–400 mg/kg/day for at least six months) increased the risk of exacerbations by 2.5 times in patients with quiescent lupus. People who interrupted the therapy exhibited constitutional symptoms of the dis"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T83","span":{"begin":193,"end":216},"obj":"Phenotype"}],"attributes":[{"id":"A83","pred":"hp_id","subj":"T83","obj":"http://purl.obolibrary.org/obo/HP_0025142"}],"text":"ing of HCQ treatment (100–400 mg/kg/day for at least six months) increased the risk of exacerbations by 2.5 times in patients with quiescent lupus. People who interrupted the therapy exhibited constitutional symptoms of the dis"}